<div id="readability-page-1"><p>Scotiabank analyst Louise Chen maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $495.00.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>According to TipRanks, Chen is a 3-star analyst with an average return of <span>1.8%</span> and a 45.60% success rate. Chen covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Amgen, and Vertex Pharmaceuticals.</p> <p>In a report released on December 5, Citi also maintained a Buy rating on the stock with a $575.00 price target.</p></div>

VRTX

<p>Scotiabank analyst Louise Chen maintained a Buy rating on Vertex Pharmaceuticals, setting a price target of $495.00. Chen, a 3-star analyst, has an average return of 1.8% and a 45.60% success rate. Citi also maintained a Buy rating with a $575.00 price target. Both analysts focus on the Healthcare sector.</p>

Scotiabank Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)